Latest S-1 registration statements

Alpha Cognition Inc. has filed an amendment to its Form S-1 registration statement, detailing its commercialization strategy for ZUNVEYL and providing updates on its clinical programs and recent corporate activities.

Foxx Development Holdings is registering up to 12,145,917 common shares for issuance upon the exercise of outstanding warrants.

Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an S-1 registration statement for a direct listing of its common stock on the NYSE, aiming to raise capital for commercializing its Sildenafil Oral Suspension and developing innovative drug delivery devices.

Aspira Women's Health is offering up to 16 million shares of common stock and pre-funded warrants to raise capital, while also facing potential delisting from the Nasdaq Capital Market.

Catalyst Crew Technologies Corp. formalizes executive roles with new employment agreements and details its strategic focus on facial recognition technology.

NAYA Biosciences enters into a warrant agency agreement with Transfer Online, Inc. for its public offering involving common stock, pre-funded warrants, and common stock purchase warrants.

Functional Brands Inc. amends its asset purchase agreement related to the Kirkman acquisition and files an S-1 registration statement for an initial public offering.

DIH Holding US, Inc. has filed an exhibit detailing the terms of a Class A Common Stock Purchase Warrant, outlining conditions for exercise and adjustments.

Eastside Distilling registers 545,406 shares for resale by selling stockholders following a private placement related to its merger with Beeline Financial.

Callan JMB Inc. has filed an amendment to its registration statement for an initial public offering of 1,280,000 shares of common stock, with an expected price between $4.00 and $6.00 per share.

Ribbon Acquisition Corp, a blank check company, has filed an amendment to its S-1 registration statement for a $50 million initial public offering.

The Marquie Group, Inc. has filed an amendment to its S-1 registration statement, primarily to include updated exhibits, including legal and accounting consents.

Allurion Technologies plans to raise capital through an offering of common stock, pre-funded warrants, and common warrants.

Oragenics is launching a public offering of up to 15,151,515 units to fund the development of its ONP-002 drug for mild traumatic brain injury.

Nuburu, Inc. has filed a registration statement for the resale of up to 1,905,904 shares of its common stock by existing stockholders, primarily related to convertible notes and advisory services, as the company faces significant financial hurdles.

International Land Alliance, Inc. has filed an amendment to its Form S-1 registration statement for a proposed public offering of its common stock, aiming for a Nasdaq Capital Market listing.

Advanced Biomed Inc., a Nevada-based holding company, plans to raise capital through a $7.5 million common stock offering to fund cancer detection technology development and market expansion.

Lazydays Holdings initiates a rights offering to raise up to $25 million, providing existing shareholders the opportunity to purchase common stock at $1.03 per share.

Plum Acquisition Corp. IV, a blank check company, filed an amendment to its Form S-1 registration statement for a proposed $150 million initial public offering.

Maze Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering to fund the development of its precision medicines targeting renal, cardiovascular, and metabolic diseases.

NAYA Biosciences has filed an amendment to its registration statement for a unit offering of up to $13 million, including common stock or pre-funded warrants and common warrants.

Flowco Holdings Inc. has filed an amendment to its S-1 registration statement for its initial public offering of Class A common stock, aiming to raise capital for debt repayment and general corporate purposes.

Maverick Lifestyle Inc. has filed an amendment to its Form S-1 registration statement, outlining details for a proposed initial public offering of its Class A Common Stock.

Drugs Made In America Acquisition Corp. files an amendment to its S-1 registration statement, primarily consisting of exhibits and updated signatures.

Beta Bionics updates its bylaws, detailing stockholder meeting procedures, director responsibilities, and indemnification policies, as the company prepares for a possible initial public offering.

Smithfield Foods, Inc. is issuing $600 million in senior notes due in 2027, guaranteed by subsidiary guarantors.

Cosmos Health Inc. is offering up to 10,714,286 shares of common stock, pre-funded warrants, and common warrants in a best-efforts offering to raise capital.

LogicMark, Inc. plans to offer units consisting of common stock and warrants to fund sales, marketing, working capital, and general corporate purposes.

OS Therapies aims to register the resale of up to $15 million in common stock through an equity line of credit, alongside commitment shares.

Eastside Distilling enters into a Common Stock Purchase Agreement with C/M Capital Partners for up to $35 million, providing financial flexibility and growth potential.